These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24942709)

  • 1. Vitamin D and nifedipine in the treatment of Chinese patients with grades I-II essential hypertension: a randomized placebo-controlled trial.
    Chen WR; Liu ZY; Shi Y; Yin DW; Wang H; Sha Y; Chen YD
    Atherosclerosis; 2014 Jul; 235(1):102-9. PubMed ID: 24942709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin D on plasma lipid profiles in statin-treated patients with hypercholesterolemia: A randomized placebo-controlled trial.
    Qin XF; Zhao LS; Chen WR; Yin DW; Wang H
    Clin Nutr; 2015 Apr; 34(2):201-6. PubMed ID: 24844869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
    Pilz S; Gaksch M; Kienreich K; Grübler M; Verheyen N; Fahrleitner-Pammer A; Treiber G; Drechsler C; Ó Hartaigh B; Obermayer-Pietsch B; Schwetz V; Aberer F; Mader J; Scharnagl H; Meinitzer A; Lerchbaum E; Dekker JM; Zittermann A; März W; Tomaschitz A
    Hypertension; 2015 Jun; 65(6):1195-201. PubMed ID: 25801871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin D supplementation versus placebo on essential hypertension in patients with vitamin D deficiency: a double-blind randomized clinical trial.
    Sheikh V; Mozaianimonfared A; Gharakhani M; Poorolajal J; Ph D
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1867-1873. PubMed ID: 32951301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial.
    Arora P; Song Y; Dusek J; Plotnikoff G; Sabatine MS; Cheng S; Valcour A; Swales H; Taylor B; Carney E; Guanaga D; Young JR; Karol C; Torre M; Azzahir A; Strachan SM; O'Neill DC; Wolf M; Harrell F; Newton-Cheh C; Wang TJ
    Circulation; 2015 Jan; 131(3):254-62. PubMed ID: 25359163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial.
    Witham MD; Ireland S; Houston JG; Gandy SJ; Waugh S; Macdonald TM; Mackenzie IS; Struthers AD
    Hypertension; 2014 Apr; 63(4):706-12. PubMed ID: 24420547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial.
    Witham MD; Price RJ; Struthers AD; Donnan PT; Messow CM; Ford I; McMurdo ME
    JAMA Intern Med; 2013 Oct; 173(18):1672-9. PubMed ID: 23939263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective controlled trial of two nifedipine extended release formulations in the treatment of essential hypertension.
    Pivac N; Naranca M; Vujic-Podlipec D; Bagatin J; Rumboldt Z
    Arzneimittelforschung; 2002; 52(5):379-84. PubMed ID: 12087923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of daily 2000 IU versus 800 IU vitamin D on blood pressure among adults age 60 years and older: a randomized clinical trial.
    Abderhalden LA; Meyer S; Dawson-Hughes B; Orav EJ; Meyer U; de Godoi Rezende Costa Molino C; Theiler R; Stähelin HB; Ruschitzka F; Egli A; Forman JP; Willett WC; Bischoff-Ferrari HA
    Am J Clin Nutr; 2020 Sep; 112(3):527-537. PubMed ID: 32542307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vitamin D supplementation as an adjuvant therapy in coronary artery disease patients.
    Wu Z; Wang T; Zhu S; Li L
    Scand Cardiovasc J; 2016; 50(1):9-16. PubMed ID: 26440923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study.
    Shimamoto K; Hasebe N; Ito S; Kario K; Kimura K; Dohi Y; Kawano Y; Rakugi H; Horiuchi M; Imaizumi T; Ohya Y
    Hypertens Res; 2014 Jan; 37(1):69-75. PubMed ID: 23945965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trial.
    Witham MD; Dove FJ; Khan F; Lang CC; Belch JJ; Struthers AD
    Int J Cardiol; 2013 Aug; 167(3):745-9. PubMed ID: 22459388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized double-blind therapeutic trial of enalapril versus timed-release nifedipine in mild to moderate essential hypertension].
    Artigou JY; Benichou M; Berland J; Fressinaud P; Grollier G; Guéret P; Nguyen Cong Duc L
    Presse Med; 1990 Jan 6-13; 19(1):13-6. PubMed ID: 2137218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial.
    Dalbeni A; Scaturro G; Degan M; Minuz P; Delva P
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):861-8. PubMed ID: 24787908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.